My Malignant Melanoma

A fellow melanoma patient asked me this week about the UK trial of a new anti-melanoma drug, a MEK inhibitor called RO4987655. Here's a clinical trial in the UK of the drug. The drug gave complete remission in an animal study, and side-effects are not too bad. It has a similar mode of action to the PLX4032 drug which is giving such hope. Sounds worth a shot.

Labels: Clinical, inhibitor, MEK, RO4987655, Trial